Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Bain, Cinven discussing new offer for Stada: sources
Bain, Cinven discussing new offer for Stada: sources
Buyout groups Bain Capital and Cinven are talking to investors about a potential new offer for German generic drugmaker Stada (STAGn.
Nigerian pharmaceutical industry needs $95 million bailout
Nigerian pharmaceutical industry needs $95 million bailout
THE Chief Executive Officer of Emzor Pharmaceuticals, Dr Stella Okoli, on Monday said the pharmaceutical industry was in need of urgent government intervention, as it required injection of funds in th...
Japan and India deal on low-cost vaccines for lower income countries
Japan and India deal on low-cost vaccines for lower income countries
Japan’s largest drugmaker Takeda Pharmaceutical (TYO.
New Roche haemophilia drug prevents bleeds but questions remain
New Roche haemophilia drug prevents bleeds but questions remain
Roche's investigational haemophilia drug emicizumab cut the bleed rate by 87 percent in patients with resistance to standard therapy compared with those who received another treatment, the Swiss c...
Novo Nordisk reports up to 13.8% weight loss in people with obesity receiving semaglutide in phase 2 trial
Novo Nordisk reports up to 13.8% weight loss in people with obesity receiving semaglutide in phase 2 trial
Bagsværd, Denmark, 23 June 2017 - Novo Nordisk today announced the headline results from a 52-week double-blind phase 2 clinical trial with once-daily subcutaneous semaglutide investigating safety a...
Finally, a drug to benefit rare kidney cancer
Finally, a drug to benefit rare kidney cancer
Washington dc_ People suffering from advanced kidney cancer, we have some good news for you.
U.S. FDA Approves Mydayis™ (mixed salts of a single-entity amphetamine product) – A New Once-Daily Option for ADHD Symptom Control in Patients 13 Years and Older
U.S. FDA Approves Mydayis™ (mixed salts of a single-entity amphetamine product) – A New Once-Daily Option for ADHD Symptom Control in Patients 13 Years and Older
Lexington, Mass.
Camber launches Micardis generic
Camber launches Micardis generic
PISCATAWAY, N.
Singapore’s pharmaceutical market set to break $1 billion mark by 2019
Singapore’s pharmaceutical market set to break $1 billion mark by 2019
The pharmaceutical market in Singapore is set to rise from $948 million in 2017 to around $1.
With pharma industry ROI down, opportunity lies with innovative development and market access strategy, says GlobalData
With pharma industry ROI down, opportunity lies with innovative development and market access strategy, says GlobalData
The pharmaceutical industry is driven by innovation in drug discovery.
Brazil’s highly attractive pharmaceutical market to approach $30 billion by 2021
Brazil’s highly attractive pharmaceutical market to approach $30 billion by 2021
The Brazilian pharmaceutical market is set to grow from $25.
FDA Working to Lift Barriers to Generic Drug Competition
FDA Working to Lift Barriers to Generic Drug Competition
By.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand